Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Capital on the Frontier Best Practices Geographies
Slack Conference Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe
Features
Series
Themes
Community
Data
Subscribe Log In
More

54gene raises $4.5 million to increase African genetic material in medical research



ImpactAlpha, July 3 –  Most human genomics data used to advance drug therapies and medical research is based on Caucasian DNA samples, which represents an increasingly small share of the global population.

To diversify medical and health discoveries, Nigerian startup 54gene has raised $4.5 million in funding to build an African DNA biobank and is seeking 40,000 samples this year.

 “The genomic revolution has taken place everywhere except for Africa,” said 54gene’s Abasi Ene-Obong. What many people don’t realize is how genetically diverse Africa is… which makes our DNA ideal for studying loss-of-function type mutations that can be replicated into new drugs.”

Health diagnostics startup StackDx secures funding from Microtraction

Launched six months ago by diagnostics startup Stack dx, the company is partnering with 10 hospitals in Nigeria in research on oncology, cardiology, neurology, endocrinology and sickle cell disease.

54gene, part of the Y Combinator accelerator, also is backed by Fifty Years, Better Ventures, KdT Ventures, Hack VC and Techammer.

You might also like...